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Purpose: To compare the levels of calcium and phosphorus in the aqueous humor and serum of diabetics 
and non-diabetics.
Methods:  We divided patients into two groups: seventy-six non-diabetic cataract patients and fifty-two 
diabetic cataract patients. The diabetic group was divided again into three subgroups: twenty-six patients 
with no diabetic retinopathy, thirteen patients with non-proliferative diabetic retinopathy, and thirteen patients 
with proliferative diabetic retinopathy. The authors compared the levels of calcium and phosphorus in the 
serum and aqueous humor of cataract patients. Statistic analysis was performed to form two comparisons: 
1) a comparison between non-diabetics and diabetics and 2) a comparison among non-diabetics and the 
three subgroups of diabetics.
Results: In serum, calcium levels did not statistically differ between non-diabetics and diabetics. The 
phosphorus level was also not significantly different. In the aqueous humor, however, while calcium levels 
did not differ significantly, the phosphorus levels in diabetics were considerably higher than those in 
non-diabetics. When non-diabetics were compared to the three diabetic subgroups, calcium levels did not 
differ in serum or aqueous humor, but the phosphorus levels in diabetics with proliferative diabetic 
retinopathy were significantly higher than those in non-diabetics, diabetics without diabetic retinopathy, and 
diabetics with non-proliferative diabetic retinopathy.
Conclusions: The level of phosphorus in the aqueous humor and serum of diabetics was significantly 
increased, especially in diabetics with proliferative diabetic retinopathy. This result may be related to 
hydrophilic acrylic IOL opacification. Future studies regarding the pathogenic role of a high concentration of 
aqueous humor and serum phosphorus are required.
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A common and effective treatment for cataracts involves 
the implantation of a foldable intraocular lens (IOL) through 
a small incision after phacoemusification of the cataract. The 
foldable IOL is often composed of hydrophilic acryl, which 
is soft, autoclave sterilizable, hydrophilic, and has superior 
biocompatibility compared with PMMA (polymethymethacrylate), 
silicone, and hydrophobic acryl.
1-6 However, the hydrophilic 
acryl hydrogel IOL is the most common type of lenses 
removed.
7 In 93% of these cases, the IOL had to be removed 
due to late opacification of the optic area of the lens.
7 Cases 
involving the opacification of hydrogel IOLs made from 
various materials and designs are steadily reported around the 
world.
8-23 In many cases, such opacification resulted from the 
deposition of calcium and phosphorus inside the IOL, outside 
the IOL or both.
8-20 Opacification is more frequently reported 
in diabetics, especially those with proliferative diabetic 
retinopathy.
17,18,22,23 In this study, the authors compared levels 
of calcium and phosphorus in the aqueous humor and serum 
of non-diabetics and diabetics to investigate the basis for the 
increased incidence of late opacification of hydrophilic 
acrylic intraocular lenses in diabetic patients.
Materials and Methods
The study included 128 patients who had undergone 
phacoemulsification with IOL implantation between Oct 23, 
2003 and Feb 23, 2005 at Seoul Veterans Hospital. Only 
senile cataract patients without a prior intraocular surgery or 
history of complications like glaucoma or uveitis were 
enrolled. The average age was 68 years old (51-84 years old) 
and the ratio of males to females was 106 to 22. Fifty two 
patients were diabetic (40.6%), and among these 26 had no 
diabetic retinopathy (20.3%), 13 had non-proliferative CJ Kim, et al. ANALYSIS OF AQUEOUS HUMOR CALCIUM AND PHOSPHATE
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No. of eyes Aqueous humor   Serum 
Ca (mg/dl)   P (mg/dl)  Ca (mg/dl)   P (mg/dl) 
Non-DM 76 5.74±0.58 2.19±0.47  9.07±0.46    3.27±0.63 
DM 
Total 52 5.88±0.57  2.57±0.63    9.17±0.58 3.38±0.76
No DMR 26 5.96±0.63 2.25±0.50 9.16±0.51 3.26±0.64
NPDR 13 5.80±0.50 2.54±0.55 9.08±0.85 3.15±0.73
PDR 13 5.80±0.52 3.03±0.63 9.08±0.85 3.88±0.83
Ca: Calcium.
P: Phosphate.
DM: diabetes mellitus.
DMR: DM retinopathy.
NPDR: non-proliferative diabetic retinopathy.
PDR: proliferative diabetic retinopathy.
Table 1. Concentrations of calcium and phosphorus in the aqueous humor and serum
diabetic retinopathy (10.2%) and 13 had proliferative 
retinopathy (10.2%).
Before surgery, we administered 2% lidocaine for local 
anesthesia, and then we made a temporal clear cornea 
incision with a 1.3 mm MVR blade and sampled 0.1~0.2 cc 
of aqueous humor with a 1 cc tuberculin syringe capped with 
an anterior irrigation tip instead of a needle. The levels of 
calcium and phosphorus in the sample were immediately 
measured with an automated analyzer (TBA-200 FR NEO 
biochemical analyzer, Toshiba) by the Department of 
Clinicopatholgy. In addition, a serum sample was obtained at 
admission, and the levels of calcium and phosphorous in this 
sample were also measured with this automated analyzer. 
The data was statistically analyzed with SPSS Win 12.0, 
using a 95% level of significance. T-Tests were used to 
compare the average values of calcium and phosphorus in the 
aqueous humor of the diabetic and non-diabetic groups. A 
one-way ANOVA was used to compare the mean values of 
calcium and phosphorus among non-diabetics and the 
three diabetic subgroups (no diabetic retinopathy, 
non-proliferative diabetic retinopathy, and proliferative 
diabetic retinopathy).
The Tukey B approach of multiple comparison tests was 
used to identify any group that differed widely from the other 
groups. A bivariate correlation analysis and a linear 
regression analysis were used to investigate the relationship 
between the four factors: calcium and phosphorus in the 
aqueous humor and in serum. 
Results
In the aqueous humor, the mean value of phosphorus in 
diabetics was 2.57±0.63 mg/dl, which was significantly 
higher than that in non-diabetics (2.19±0.47 mg/dl) 
(p=0.002), but there was no significant difference in calcium 
levels between diabetics and non-diabetics (p=0.19). In 
serum, neither calcium nor phosphorus differed significantly 
between the two groups (independent T-test, serum calcium 
p=0.253, serum phosphorus p=0.34).
When the non-diabetics were compared to the 3 subgroups 
of diabetics (diabetics without diabetic retinopathy, non- 
proliferative diabetic retinopathy, and proliferative diabetic 
retinopathy), phosphorus in the aqueous humor and serum 
differed notably, but calcium did not differ significantly in 
either fluid compartment (one-way ANOVA, aqueous humor 
phosphorus p=0.000, serum phosphorus p=0.02, serum 
calcium p=0.453, serum calcium p=0.476) (Table 1).
The mean values of serum phosphorus and aqueous humor 
phosphorus were not significantly different among non- 
diabetics, diabetics without diabetic retinopathy, and those 
with non-proliferative diabetic retinopathy. However, the 
mean value of serum and aqueous humor phosphorus in 
diabetics with proliferative diabetic retinopathy was much 
higher than that in the other three groups (Tukey B, aqueous 
humor phosphorus p<0.05, serum phosphorus p<0.05) (Fig. 
1. and Fig. 2.).
The level of aqueous humor phosphorus and serum 
phosphorus were significantly correlated to one another 
(bivariate correlation analysis, r=0.218, p=0.031), but were 
not correlated to calcium serum or aqueous humor levels. The 
level of aqueous humor phosphorus was related to the level 
of serum phosphorus by linear regression analysis, and the 
simple regression equation was determined to be: aqueous 
humor phosphorus=1.731+0.185 X (serum phosphorus) 
(linear regression analysis, F=4.817, p=0.031) (Fig. 3).
Conclusions
The opacification of hydrophilic acrylic foldable 
intraocular lenses has been reported in many cases around the 
world since Chang et al
12's report, and possible causes for 
this opacification have been suggested.
8-20 The opacifications 
are induced by hydroxyapatite, containing calcium and 
phosphorus, as demonstrated by von Kossa stain, Alizarin red 
stain, scanning Electron microscope (SEM), FR-IR 
spectrometer, X-ray photoelectron spectroscopy, and energy 
dispersive X-ray spectroscopy.
8,16-20Kor J Ophthalmol Vol.21, No.2, 2007
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Fig. 1. Boxplot of the concentration of phosphorus in the 
aqueous humor.
Fig. 2. Boxplot of the concentration of phosphorus in serum.
Fig. 3. regression analysis of the concentration of phosphorus 
in the aqueous humor with respect to the concentration of
phosphorus in serum.
Werner et al
11 reported that the source of this excessive 
calcium was residual lens substance. In normal aqueous 
humor, calcium is found in low concentrations (about half of 
serum calcium), and an increase in these levels caused by 
intraocular inflammation, high calcium or phosphorus in 
intraocular drug administration, or intraoperative perfusates 
may cause dystrophic calcification. However, those 
intraoperative perfusates and viscoelastics have little direct 
relation to the opacification in question, since the 
opacification occurs long after the surgery and the materials 
are not used equally in all cases.
The intraocular lens itself has been considered important 
in the causation of IOL opacification. However, 
opacifications are not found in all patients operated on by the 
same surgeon, using the same surgical materials. Kim et al
21 
reported that opacification occurred in 70 out of 91 eyes 
(85.4%) selected from 69 patients observed for more than 6 
months after implanting the ACRL-C160 intraocular lenses. 
In an unpublished study at our hospital, opacification 
occurred in 33 out of 91 eyes (39%) selected from 77 
patients observed for about 23.2 months after implanting 
ACRL-C160 intraocular lenses. The authors could confirm 
that not all patients experience opacification, even though the 
incidence differed from that of Kim's report. Therefore, the 
IOL opacification cannot be attributed to the IOL alone, but 
may rely on other factors that alter the intraocular 
environment, such as an increase in the aqueous calcium and 
phosphorus or an acceleration of their deposition. Systemic 
diseases like diabetes and hypertension have been proposed 
as a major factor in the etiology of opacification. Specifically, 
diabetes mellitus has been reported as the most frequent 
cause of opacification among various systemic diseases. Groh 
MJ et al
22 reported that 6 of 12 patients with IOL 
opacification had diabetes. Werner et al
11 remarked that 
metabolic imbalance is an essential factor in the causation of 
IOL opacification, observing that most patients with IOL 
opacification also had cardiovascular disease, arthritis, 
hypertension, or diabetes. Neuhann et al
23 reported that 
diabetes was the systemic disease most frequently 
accompanied by IOL in a study in which opacified IOLs 
were removed from 106 eyes. Lee et al
17 considered diabetes 
a triggering factor for IOL opacification because all 4 patients 
that underwent IOL exchange had diabetes. Ha et al
18 
remarked that increased intraocular calcium levels may be a 
direct cause of IOL opacification considering that the patients 
in his study were all diabetics who had proliferative diabetic CJ Kim, et al. ANALYSIS OF AQUEOUS HUMOR CALCIUM AND PHOSPHATE
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retinopathy for more than 10 years. In an unpublished study 
from our hospital, 18 out of 33 eyes (67%) selected from 
patients who had IOL opacification were accompanied by 
diabetes. However some reports suggest that IOL 
opacification is not significantly related to diabetes.
20,21 In a 
study investigating the relationship between IOL 
opacification and systemic disease, Kim et al
21 remarked that 
diabetes did not significantly affect the occurrence of 
opacification but that opacification progressed faster in 
patients with diabetes, especially in those that had 
long-standing disease. The opacification also appeared both 
accelerated and more severe in patients with proliferative 
diabetic retinopathy. 
Several researchers have reported that IOL opacification 
occurred more frequently, faster, and more severely in the 
eyes of diabetics. They have also suggested that levels of 
aqueous humor calcium may be causatively related. Pombo 
et al
24 extracted the vitreous of patients with proliferative 
diabetic retinopathy and proliferative vitreoretinopathy and 
found that the ATP released from blood vessels of the retina 
induced an increase in calcium. They also found that high 
levels of prorenin were found in patients with proliferative 
diabetic retinopathy, which produces angiotensin I and 
increases calcium levels. Some researchers reported that 
cytokine-like vascular endothelial growth factor (VEGF) 
increases the permeability of the blood-aqueous barrier and 
continuously promotes cell-mediated inflammation. The 
levels of albumin, glucose, and sulfur remained high, 
compared with normal eyes, due to the damaged 
blood-aqueous barrier present in diabetic retinopathy.
25
The levels of aqueous humor calcium were not statistically 
different between diabetics and non-diabetics or among 
non-diabetics and the three subgroups of diabetics. This 
contradicted our expectation that increased permeability of 
the blood-aqueous barrier would increase aqueous humor 
calcium levels in patients with proliferative diabetic 
retinopathy. It is difficult to simply compare this study with 
Kim et al
21's study since Kim et al compared serum calcium 
and phosphorus between an opacified IOL group and a 
non-opacified IOL group.
The high concentration of serum and aqueous humor 
phosphorus in diabetics with proliferative diabetic retinopathy 
is thought to result from renal insufficiency in diabetes 
mellitus. When high levels of phosphorus are maintained for 
long periods, the driving force for mineralization is increased, 
and calcium phosphate may be deposited in abnormal sites 
(ectopic calcification).
26
Many articles report that high serum phosphate levels with 
normal calcium levels may influence vascular, prosthetic 
valvular, and extraskeletal calcifications by three 
separate mechanisms: by ectopic calcification resulting 
from hyperphosphatemia, by worsening secondary 
hyperparathyroidism, which in turn facilitates calcification, 
and by promoting calcium phosphate deposition in 
pre-formed endothelial plaques in the arterial wall.
27,28
If increased aqueous humor and serum phosphorus may 
induce IOL opacification by promoting the formation of a 
calcium-phosphorus compound, our finding that aqueous 
humor and serum phosphorus were elevated in patients with 
proliferative diabetic retinopathy may explain the preponderance 
of patients with proliferative diabetic retinopathy that 
experience IOL opacification.
Future studies should explore the role of elevated serum 
and aqueous humor phosphorus in the pathogenesis of 
hydrophilic acrylic IOL opacification, especially in diabetics 
with proliferative diabetic retinopathy.
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